Literature DB >> 28611787

Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality.

João Pedro Ferreira1,2, Nicolas Girerd1, Pedro Bettencourt Medeiros3, Miguel Bento Ricardo3, Tiago Almeida3, Alexandre Rola3, Faiez Zannad1, Patrick Rossignol1, Irene Aragão4.   

Abstract

INTRODUCTION: The assessment of the amount of urine produced by the dose of administered diuretic has been proposed as the main signal of interest in diuretic responsiveness - diuretic efficiency (DE). The main aim of our study is to determine if a low DE is associated with 180-day all-cause mortality (ACM).
METHODS: During a 3-year period, we retrospectively studied patients with acutely decompensated heart failure (ADHF) and respiratory insufficiency admitted to the emergency room of a tertiary university hospital in Porto, Portugal. A total of 170 patients (age 76.2 ± 10.3 years) were included. The outcome of ACM occurred in 43 (25.3%) patients during the 180-day follow-up period. DE was evaluated for a maximum of 3 h after emergency room admission. The lowest DE was defined as ≤140 mL of diuresis per 40 mg of furosemide equivalents.
RESULTS: No significant differences in age, comorbidities, baseline HF symptoms, or disease-modifying medication were found between the lowest and highest DE groups. The lowest DE group had higher blood urea and lower estimated glomerular filtration rate (eGFR) levels (41.3 ± 24.5 vs. 56.7 ± 23.2 mL/min/1.73 m2, p < 0.001). The patients with the lowest DE had significantly higher rates of ACM during the 180-day follow-up, even after adjustment for other clinically relevant variables: hazard ratio (HR) [95% CI] = 2.31 [1.16-4.58], p = 0.016. The lowest diuresis (≤300 mL) and the highest intravenous furosemide dose (>80 mg) alone were not significantly associated with the outcome. After adjustment for N-terminal prohormone of brain natriuretic peptide, the association between the lowest DE and the outcome lost strength (HR [95% CI] = 1.53 [0.75-3.13], p = 0.240).
CONCLUSION: A low DE (≤140 mL/40 mg of furosemide) in the first 3 h after an ADHF episode was associated with increased mid-term mortality rates.

Entities:  

Keywords:  Acutely decompensated heart failure; Diuresis; Diuretic efficiency; Survival

Year:  2017        PMID: 28611787      PMCID: PMC5465746          DOI: 10.1159/000455903

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  31 in total

1.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

Review 2.  Loop diuretics and ultrafiltration in heart failure.

Authors:  Patrick Rossignol; Faiez Zannad
Journal:  Expert Opin Pharmacother       Date:  2013-06-25       Impact factor: 3.889

3.  Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

Authors:  João Pedro Ferreira; Mário Santos; Sofia Almeida; Irene Marques; Paulo Bettencourt; Henrique Carvalho
Journal:  Eur J Intern Med       Date:  2013-09-23       Impact factor: 4.487

4.  Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.

Authors:  Mehmet Birhan Yilmaz; Etienne Gayat; Reda Salem; Johan Lassus; Maria Nikolaou; Said Laribi; John Parissis; Ferenc Follath; W Franck Peacock; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2011-11       Impact factor: 15.534

5.  Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.

Authors:  Justin L Grodin; Susanna R Stevens; Lisa de Las Fuentes; Michael Kiernan; Edo Y Birati; Divya Gupta; Bradley A Bart; G Michael Felker; Horng H Chen; Javed Butler; Victor G Dávila-Román; Kenneth B Margulies; Adrian F Hernandez; Kevin J Anstrom; W H Wilson Tang
Journal:  J Card Fail       Date:  2015-07-21       Impact factor: 5.712

6.  Diuretic response in acute heart failure: clinical characteristics and prognostic significance.

Authors:  Mattia A E Valente; Adriaan A Voors; Kevin Damman; Dirk J Van Veldhuisen; Barrie M Massie; Christopher M O'Connor; Marco Metra; Piotr Ponikowski; John R Teerlink; Gad Cotter; Beth Davison; John G F Cleland; Michael M Givertz; Daniel M Bloomfield; Mona Fiuzat; Howard C Dittrich; Hans L Hillege
Journal:  Eur Heart J       Date:  2014-02-28       Impact factor: 29.983

7.  N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

Authors:  Paulo Bettencourt; Ana Azevedo; Joana Pimenta; Fernando Friões; Susana Ferreira; António Ferreira
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

8.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

Authors:  Bradley A Bart; Steven R Goldsmith; Kerry L Lee; Michael M Givertz; Christopher M O'Connor; David A Bull; Margaret M Redfield; Anita Deswal; Jean L Rouleau; Martin M LeWinter; Elizabeth O Ofili; Lynne W Stevenson; Marc J Semigran; G Michael Felker; Horng H Chen; Adrian F Hernandez; Kevin J Anstrom; Steven E McNulty; Eric J Velazquez; Jenny C Ibarra; Alice M Mascette; Eugene Braunwald
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245

9.  Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Authors:  Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

10.  Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.

Authors:  Nicolas Girerd; Peter S Pang; Karl Swedberg; Angela Fought; Mary J Kwasny; Haris Subacius; Marvin A Konstam; Aldo Maggioni; Mihai Gheorghiade; Faiez Zannad
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

View more
  3 in total

Review 1.  Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure.

Authors:  Frederik Hendrik Verbrugge
Journal:  Curr Heart Fail Rep       Date:  2019-12

2.  Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.

Authors:  Dominique Dos Reis; Laurie Fraticelli; Adrien Bassand; Stéphane Manzo-Silberman; Nicolas Peschanski; Sandrine Charpentier; Meyer Elbaz; Dominique Savary; Eric Bonnefoy-Cudraz; Said Laribi; Patrick Henry; Abdallah Guerraoui; Karim Tazarourte; Tahar Chouihed; Carlos El Khoury
Journal:  BMJ Open       Date:  2019-01-15       Impact factor: 2.692

Review 3.  Practical outpatient management of worsening chronic heart failure.

Authors:  Nicolas Girerd; Nathan Mewton; Jean-Michel Tartière; Damien Guijarro; Patrick Jourdain; Thibaud Damy; Nicolas Lamblin; Antoni Bayes-Génis; Pierpaolo Pellicori; James L Januzzi; Patrick Rossignol; François Roubille
Journal:  Eur J Heart Fail       Date:  2022-04-27       Impact factor: 17.349

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.